Domov › Rak jajčnikov › Texas › San Antonio
Klinične študije za Rak jajčnikov v San Antonio, TX
31 študij za Rak jajčnikov išče udeležence na lokacijah v San Antonio in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Research Site, San Antonio
A Study of PHST001 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- START Center for Cancer Research - San Antonio, San Antonio
- University of Texas (UT) Health, San Antonio
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Vključevanje udeležencevFaza 1
- South Texas Accelerated Research Therapeutics (START), San Antonio
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- New Experimental Therapeutics of San Antonio - NEXT Oncology, San Antonio
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Vključevanje udeležencevFaza 1
- NEXT Oncology - San Antonio /ID# 278606, San Antonio
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Vključevanje udeležencevFaza 1/2
- NEXT Oncology, San Antonio
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology - PARENT, San Antonio
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Vključevanje udeležencevFaza 2
- Texas Oncology - San Antonio Medical Center - Research Drive /ID# 275090, San Antonio
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Vključevanje udeležencevFaza 2
- Texas Oncology - San Antonio Medical Center - Research Drive /ID# 277735, San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Vključevanje udeležencevFaza 1/2
- START Center for Cancer Research, San Antonio
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Vključevanje udeležencevFaza 2
- Texas Oncology-San Antonio Medical Center Pharmacy, San Antonio
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Vključevanje udeležencevOpazovalna študija
- The University of Texas Health Science Center at San Antonio, San Antonio
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Vključevanje udeležencevFaza 1
- START - San Antonio, San Antonio
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Vključevanje udeležencevFaza 3
- University Of Texas Health Science Center -San Antonio ( Site 0095), San Antonio
- Texas Oncology - San Antonio ( Site 8005), San Antonio
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Vključevanje udeležencevFaza 1
- START San Antonio, San Antonio
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- UT Health San Antonio - MD Anderson Cancer Center, San Antonio
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Vključevanje udeležencevFaza 1
- Normunity Investigational Site, San Antonio
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- START San Antonio, San Antonio
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Clinical Trial Site, San Antonio
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- START - San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- South Texas Accelerated Research Therapeutics, San Antonio
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Texas Oncology - San Antonio, San Antonio
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT San Antonio, San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- START San Antonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- START, San Antonio
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
Vključevanje udeležencevVabljeni zdravi prostovoljci
- UT Health Science Center San Antonio, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology San Antonio, San Antonio
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- START San Antonio, San Antonio
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Vključevanje udeležencevFaza 1
- Dren Investigational Site, San Antonio
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Exelixis Clinical Site #3, San Antonio
Študije za Rak jajčnikov v drugih mestih
- Houston, TX89 študij
- New York City, NY69 študij
- Boston, MA61 študij
- Los Angeles, CA50 študij
- Nashville, TN49 študij
- Arlington, VA46 študij
- Philadelphia, PA44 študij
- Columbus, OH39 študij
- St. Louis, MO38 študij
- Chicago, IL36 študij
- Cleveland, OH30 študij
- Pittsburgh, PA30 študij
Druge študije v San Antonio
- Nemalicelični pljučni rak59 študij
- Rak dojke47 študij
- Kolorektalni rak46 študij
- Metastatski rak44 študij
- Rak (vse vrste)41 študij
- Debelost40 študij
- Sladkorna bolezen tipa 237 študij
- Prekomerna telesna teža34 študij
- Rak trebušne slinavke31 študij
- Rak prostate28 študij
- Rak endometrija27 študij
- Rak pljuč26 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.